Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon B Dimmitt

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Journal of the American College of Cardiology|September 17, 2016
Trading Lower HbA1c for Increased Adverse Events: A Zero Sum Game?Simon B Dimmitt, John B Warren, Jennifer H Martin, et al.
Lancet (London, England)|March 15, 2018
Clinical benefits of evolocumab appear less than hopedSimon B Dimmitt, Hans G Stampfer, Jennifer H Martin, et al.
Journal of the American College of Cardiology|October 13, 2022
High-Dose Statins Increase Adverse Events and Do Not Improve SurvivalSimon B Dimmitt, Hans G Stampfer, John B Warren, et al.
British Journal of Clinical Pharmacology|June 21, 2019
Efficacy and toxicity of antihypertensive pharmacotherapy relative to effective dose 50Simon B Dimmitt, Hans G Stampfer, Jennifer H Martin, et al.
Pharmacology Research & Perspectives|December 16, 2025
Rethinking Statin Dosage in Coronary DiseaseSimon B Dimmitt, Hans G Stampfer, Michael C Kennedy, et al.
Journal of the American College of Cardiology|February 14, 2015
Statin dose based on limited evidenceSimon B Dimmitt, Hans G Stampfer, Alicia Moran, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of the American College of Cardiology|September 17, 2016
Trading Lower HbA1c for Increased Adverse Events: A Zero Sum Game?Simon B Dimmitt, John B Warren, Jennifer H Martin, et al.
Lancet (London, England)|March 15, 2018
Clinical benefits of evolocumab appear less than hopedSimon B Dimmitt, Hans G Stampfer, Jennifer H Martin, et al.
Journal of the American College of Cardiology|October 13, 2022
High-Dose Statins Increase Adverse Events and Do Not Improve SurvivalSimon B Dimmitt, Hans G Stampfer, John B Warren, et al.
British Journal of Clinical Pharmacology|June 21, 2019
Efficacy and toxicity of antihypertensive pharmacotherapy relative to effective dose 50Simon B Dimmitt, Hans G Stampfer, Jennifer H Martin, et al.
Pharmacology Research & Perspectives|December 16, 2025
Rethinking Statin Dosage in Coronary DiseaseSimon B Dimmitt, Hans G Stampfer, Michael C Kennedy, et al.
Journal of the American College of Cardiology|February 14, 2015
Statin dose based on limited evidenceSimon B Dimmitt, Hans G Stampfer, Alicia Moran, et al.
Pageof 3